Design Pharmaceuticals, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Design Pharmaceuticals, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2022.
Design Pharmaceuticals at a glance
What does Design Pharmaceuticals do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3 million sold (2022).
Frequently asked questions about Design Pharmaceuticals
Where is Design Pharmaceuticals headquartered?
Design Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Design Pharmaceuticals do?
Design Pharmaceuticals, Inc. is a biotechnology company.
When was Design Pharmaceuticals founded?
The earliest incorporation on record for Design Pharmaceuticals, Inc. is in 2018, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences